Prospective Evidence Generation Solutions

Elevate Your Real-World Evidence Strategy with Verana Health

Verana Health’s Prospective Evidence Generation solution helps sponsors and CROs generate reliable, actionable evidence through efficient data collection and analysis. Powered by Verana Health’s exclusive, curated real-world data (RWD) and advanced analytics, our solution supports a range of study designs, including prospective observational studies, long-term follow-up, hybrid models, and pragmatic trials.

Whether you are enhancing your real-world evidence (RWE) strategy, supporting drug and device lifecycles, or streamlining clinical development, this is the solution needed to take your clinical research to the next level.

Key Features of Verana Health’s Prospective Evidence Generation Solution

Qdata® & Verana Trial Connect Integration

Verana Health’s Qdata modules are longitudinal, disease-specific data collections designed to power research with high-quality insights across the drug and device lifecycle. Combined with our site-facing Verana Trial Connect tool, our solution supports robust prospective real-world evidence generation, ensuring trials and studies achieve actionable, protocol-specific results.

Custom Data Curation

Enhance your study with Verana Health’s customizable curation capabilities. Tailor Qdata to meet your protocol’s specific evidence needs, ensuring that the data powering your study aligns with your unique research objectives.

Technology-Enabled Research Network

Leverage Verana Health’s extensive, scalable research network to identify the best-suited practices for participation in your study. Our existing relationships with practices streamline operationalization, accelerating study setup and execution.

Comprehensive Data Integration

Our solution is designed to integrate seamlessly with other RWD sources, such as claims, lab data, and patient-reported outcomes (PROs). This ensures a comprehensive, de-identified, patient-level longitudinal analysis to answer your most pressing research questions.

Why Choose Verana Health for Prospective Evidence Generation?

Powered by Exclusive Real-World Data

Verana Health offers access to exclusive RWD through its partnerships with the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) and the American Urological Association (AUA) Quality (AQUA)® Registry. The data is refreshed monthly and spans nearly 80M de-identified patients in the IRIS Registry and 12M de-identified patients in the AQUA Registry.

With about14 Qdata indications, and the ability to track patients longitudinally, Verana Health’s PEG solution provides robust, credible evidence for a wide range of research needs.

AAO
AUA
For Ophthalmology
For Urology

Scalability and Efficiency

Verana Health’s vast RWD network ensures rapid and efficient site identification and participation. Our point-of-care data collection minimizes errors and maximizes accuracy, delivering high-quality data for prospective studies.

Advanced Data and Analytics

With artificial intelligence-driven analytics and advanced tokenization, Verana Health enables the long-term follow-up of trial patients. Our infrastructure supports linking with other RWD sources, creating an enriched data environment that ensures comprehensive evidence generation across the study lifecycle.

Supporting Data

~80M De-identified Patients in the IRIS Registry
~12M Patients in the AQUA Registry
~14 Qdata indications available for disease-specific research

Monthly refreshed data for the most up-to-date insights

Access to point-of-care data and longitudinal tracking

Seamless integration with external RWD sources

Prospective Evidence Generation for Sponsors and CROs

Sponsors

Verana Health’s prospective evidence generation solution enables clinical development and medical affairs teams to streamline and enhance clinical trial design, regulatory submissions, and post-marketing surveillance. The real-world evidence that’s generated supports drug approvals, label expansions, value-based care decisions, and health technology assessments (HTA).

CROs

Deliver more efficient, higher quality data derived directly from EHRs at the point of care. Verana Health eliminates the burden of entering data in the electronic data capture (EDC) system and potential data entry errors, ensuring data integrity and accuracy in prospective studies.

Featured Content

Press

Verana Health Launches Real-World Evidence-Driven Solution for Clinical Trial Site Selection

June 2023
→
Blog

Empowering a Real-World Data-Driven Approach to Clinical Trial Site Selection

June 2023
→
Blog

Verana Health Marks Milestone with 2022 MIPS Submissions for IRIS Registry and Axon Registry

May 2023
→

Generate reliable, actionable evidence with Verana Health’s Prospective Evidence Generation Solution.

Our comprehensive data, scalable network, and advanced analytics will help you enhance your real-world evidence strategy and drive successful clinical research outcomes. Speak with an expert to learn more about Prospective Evidence Generation.